A Moving Residual Limb: Botulinum Toxin to the Rescue
Movement disorders post-amputation are a rare complication and can manifest as the jumping stump phenomenon, a form of peripheral myoclonus. The pathophysiology remains unknown and there is currently no standardized treatment. We describe the case of a 57-year-old male with unremitting stump myoclon...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
De Gruyter
2020-02-01
|
Series: | Translational Neuroscience |
Subjects: | |
Online Access: | https://doi.org/10.1515/tnsci-2020-0006 |
id |
doaj-1c419959fbf14b71b2eaa2673d4d2810 |
---|---|
record_format |
Article |
spelling |
doaj-1c419959fbf14b71b2eaa2673d4d28102021-09-05T20:51:32ZengDe GruyterTranslational Neuroscience2081-69362020-02-01111343710.1515/tnsci-2020-0006tnsci-2020-0006A Moving Residual Limb: Botulinum Toxin to the RescueBriand Marie-Michèle0Boudier-Réveret Mathieu1Rodrigue Xavier2Sirois Geneviève3Chang Min Cheol4Institut de réadaptation en déficience physique de Québec, Québec, CanadaDepartment of Physical Medicine and Rehabilitation, Centre hospitalier de l'Université de Montréal, Montreal, CanadaInstitut de réadaptation en déficience physique de Québec, Québec, CanadaInstitut de réadaptation en déficience physique de Québec, Québec, CanadaDepartment of Physical Medicine and Rehabilitation, College of Medicine, Yeungnam University 317-1, Daemyungdong, Namku, Taegu 705-717, Republic of KoreaMovement disorders post-amputation are a rare complication and can manifest as the jumping stump phenomenon, a form of peripheral myoclonus. The pathophysiology remains unknown and there is currently no standardized treatment. We describe the case of a 57-year-old male with unremitting stump myoclonus, starting one month after transtibial amputation, in his residual limb without associated phantom or neurological pain. The consequence of the myoclonus was a reduction in prosthetic wearing time. Failure to respond to oral medication led us to attempt the use of botulinum neurotoxin Type A injections in the involved muscles of the residual limb. Injection trials, over a two-year period, resulted in an improvement of movement disorder, an increased prosthetic wearing time and a higher satisfaction level of the patient. Injection of botulinum toxin type A should be considered as an alternative treatment for stump myoclonus to improve prosthetic wearing time and comfort.https://doi.org/10.1515/tnsci-2020-0006amputation stumpmyoclonusmovement disordersbotulinum toxin |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Briand Marie-Michèle Boudier-Réveret Mathieu Rodrigue Xavier Sirois Geneviève Chang Min Cheol |
spellingShingle |
Briand Marie-Michèle Boudier-Réveret Mathieu Rodrigue Xavier Sirois Geneviève Chang Min Cheol A Moving Residual Limb: Botulinum Toxin to the Rescue Translational Neuroscience amputation stump myoclonus movement disorders botulinum toxin |
author_facet |
Briand Marie-Michèle Boudier-Réveret Mathieu Rodrigue Xavier Sirois Geneviève Chang Min Cheol |
author_sort |
Briand Marie-Michèle |
title |
A Moving Residual Limb: Botulinum Toxin to the Rescue |
title_short |
A Moving Residual Limb: Botulinum Toxin to the Rescue |
title_full |
A Moving Residual Limb: Botulinum Toxin to the Rescue |
title_fullStr |
A Moving Residual Limb: Botulinum Toxin to the Rescue |
title_full_unstemmed |
A Moving Residual Limb: Botulinum Toxin to the Rescue |
title_sort |
moving residual limb: botulinum toxin to the rescue |
publisher |
De Gruyter |
series |
Translational Neuroscience |
issn |
2081-6936 |
publishDate |
2020-02-01 |
description |
Movement disorders post-amputation are a rare complication and can manifest as the jumping stump phenomenon, a form of peripheral myoclonus. The pathophysiology remains unknown and there is currently no standardized treatment. We describe the case of a 57-year-old male with unremitting stump myoclonus, starting one month after transtibial amputation, in his residual limb without associated phantom or neurological pain. The consequence of the myoclonus was a reduction in prosthetic wearing time. Failure to respond to oral medication led us to attempt the use of botulinum neurotoxin Type A injections in the involved muscles of the residual limb. Injection trials, over a two-year period, resulted in an improvement of movement disorder, an increased prosthetic wearing time and a higher satisfaction level of the patient. Injection of botulinum toxin type A should be considered as an alternative treatment for stump myoclonus to improve prosthetic wearing time and comfort. |
topic |
amputation stump myoclonus movement disorders botulinum toxin |
url |
https://doi.org/10.1515/tnsci-2020-0006 |
work_keys_str_mv |
AT briandmariemichele amovingresiduallimbbotulinumtoxintotherescue AT boudierreveretmathieu amovingresiduallimbbotulinumtoxintotherescue AT rodriguexavier amovingresiduallimbbotulinumtoxintotherescue AT siroisgenevieve amovingresiduallimbbotulinumtoxintotherescue AT changmincheol amovingresiduallimbbotulinumtoxintotherescue AT briandmariemichele movingresiduallimbbotulinumtoxintotherescue AT boudierreveretmathieu movingresiduallimbbotulinumtoxintotherescue AT rodriguexavier movingresiduallimbbotulinumtoxintotherescue AT siroisgenevieve movingresiduallimbbotulinumtoxintotherescue AT changmincheol movingresiduallimbbotulinumtoxintotherescue |
_version_ |
1717783614506139648 |